PRESS RELEASE published on 04/18/2023 at 14:30, 2 years 7 months ago Identillect’s Delivery Trust(R) Platform Chosen by Volunteers of America of Eastern Washington and Northern Idaho for HIPAA-Compliant Email Security
PRESS RELEASE published on 04/12/2023 at 14:30, 2 years 7 months ago Identillect Selected by Consumer Products Firm Diamcers for Cybersecurity Protections Across Mexico
PRESS RELEASE published on 04/11/2023 at 14:30, 2 years 7 months ago Identillect's Delivery Trust Selected by Twin Dolphin to Secure Its Corporate Email
PRESS RELEASE published on 03/30/2023 at 14:30, 2 years 8 months ago Identillect Expands Presence in Mexico
PRESS RELEASE published on 03/23/2023 at 13:30, 2 years 8 months ago Identillect Partners with Avit Soluciones in Mexico
PRESS RELEASE published on 03/13/2023 at 19:50, 2 years 8 months ago Identillect CEO to Provide Artificial Intelligence Presentation at Export Maquiladoras Conference
Published on 12/05/2025 at 02:35, 5 hours 33 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 8 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 3 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 8 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 1 hour 8 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 37 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 17 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 42 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 53 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 53 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 8 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 8 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 23 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 23 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
